These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 32955072)

  • 1. Integrated human organ-on-a-chip model for predictive studies of anti-tumor drug efficacy and cardiac safety.
    Chramiec A; Teles D; Yeager K; Marturano-Kruik A; Pak J; Chen T; Hao L; Wang M; Lock R; Tavakol DN; Lee MB; Kim J; Ronaldson-Bouchard K; Vunjak-Novakovic G
    Lab Chip; 2020 Nov; 20(23):4357-4372. PubMed ID: 32955072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue-Engineered Bone Tumor as a Reproducible Human in Vitro Model for Studies of Anticancer Drugs.
    Sakolish C; House JS; Chramiec A; Liu Y; Chen Z; Halligan SP; Vunjak-Novakovic G; Rusyn I
    Toxicol Sci; 2020 Jan; 173(1):65-76. PubMed ID: 31626302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biomechanical regulation of drug sensitivity in an engineered model of human tumor.
    Marturano-Kruik A; Villasante A; Yaeger K; Ambati SR; Chramiec A; Raimondi MT; Vunjak-Novakovic G
    Biomaterials; 2018 Jan; 150():150-161. PubMed ID: 29040875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modeling Stroma-Induced Drug Resistance in a Tissue-Engineered Tumor Model of Ewing Sarcoma.
    Santoro M; Menegaz BA; Lamhamedi-Cherradi SE; Molina ER; Wu D; Priebe W; Ludwig JA; Mikos AG
    Tissue Eng Part A; 2017 Jan; 23(1-2):80-89. PubMed ID: 27923328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multi-tissue interactions in an integrated three-tissue organ-on-a-chip platform.
    Skardal A; Murphy SV; Devarasetty M; Mead I; Kang HW; Seol YJ; Shrike Zhang Y; Shin SR; Zhao L; Aleman J; Hall AR; Shupe TD; Kleensang A; Dokmeci MR; Jin Lee S; Jackson JD; Yoo JJ; Hartung T; Khademhosseini A; Soker S; Bishop CE; Atala A
    Sci Rep; 2017 Aug; 7(1):8837. PubMed ID: 28821762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Organ-on-a-Chip: A Preclinical Microfluidic Platform for the Progress of Nanomedicine.
    Rodrigues RO; Sousa PC; Gaspar J; Bañobre-López M; Lima R; Minas G
    Small; 2020 Dec; 16(51):e2003517. PubMed ID: 33236819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heart-on-a-chip platforms and biosensor integration for disease modeling and phenotypic drug screening.
    Criscione J; Rezaei Z; Hernandez Cantu CM; Murphy S; Shin SR; Kim DH
    Biosens Bioelectron; 2023 Jan; 220():114840. PubMed ID: 36402101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flow perfusion effects on three-dimensional culture and drug sensitivity of Ewing sarcoma.
    Santoro M; Lamhamedi-Cherradi SE; Menegaz BA; Ludwig JA; Mikos AG
    Proc Natl Acad Sci U S A; 2015 Aug; 112(33):10304-9. PubMed ID: 26240353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human Induced Pluripotent Stem-Cardiac-Endothelial-Tumor-on-a-Chip to Assess Anticancer Efficacy and Cardiotoxicity.
    Weng KC; Kurokawa YK; Hajek BS; Paladin JA; Shirure VS; George SC
    Tissue Eng Part C Methods; 2020 Jan; 26(1):44-55. PubMed ID: 31797733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Organ-on-Chip platforms to study tumor evolution and chemosensitivity.
    Dsouza VL; Kuthethur R; Kabekkodu SP; Chakrabarty S
    Biochim Biophys Acta Rev Cancer; 2022 May; 1877(3):188717. PubMed ID: 35304293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor-on-chip modeling of organ-specific cancer and metastasis.
    Del Piccolo N; Shirure VS; Bi Y; Goedegebuure SP; Gholami S; Hughes CCW; Fields RC; George SC
    Adv Drug Deliv Rev; 2021 Aug; 175():113798. PubMed ID: 34015419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Xenograft and genetically engineered mouse model systems of osteosarcoma and Ewing's sarcoma: tumor models for cancer drug discovery.
    Sampson VB; Kamara DF; Kolb EA
    Expert Opin Drug Discov; 2013 Oct; 8(10):1181-9. PubMed ID: 23844615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ewing sarcoma: The clinical relevance of the insulin-like growth factor 1 and the poly-ADP-ribose-polymerase pathway.
    van Maldegem AM; Bovée JV; Peterse EF; Hogendoorn PC; Gelderblom H
    Eur J Cancer; 2016 Jan; 53():171-80. PubMed ID: 26765686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modeling the Tumor Microenvironment and Pathogenic Signaling in Bone Sarcoma.
    Molina ER; Chim LK; Barrios S; Ludwig JA; Mikos AG
    Tissue Eng Part B Rev; 2020 Jun; 26(3):249-271. PubMed ID: 32057288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microengineered 3D Tumor Models for Anti-Cancer Drug Discovery in Female-Related Cancers.
    Amirghasemi F; Adjei-Sowah E; Pockaj BA; Nikkhah M
    Ann Biomed Eng; 2021 Aug; 49(8):1943-1972. PubMed ID: 33403451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor-on-a-chip model for advancement of anti-cancer nano drug delivery system.
    Tian C; Zheng S; Liu X; Kamei KI
    J Nanobiotechnology; 2022 Jul; 20(1):338. PubMed ID: 35858898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-Content Assessment of Cardiac Function Using Heart-on-a-Chip Devices as Drug Screening Model.
    Conant G; Lai BFL; Lu RXZ; Korolj A; Wang EY; Radisic M
    Stem Cell Rev Rep; 2017 Jun; 13(3):335-346. PubMed ID: 28429185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Microvascularized Tumor-mimetic Platform for Assessing Anti-cancer Drug Efficacy.
    Pradhan S; Smith AM; Garson CJ; Hassani I; Seeto WJ; Pant K; Arnold RD; Prabhakarpandian B; Lipke EA
    Sci Rep; 2018 Feb; 8(1):3171. PubMed ID: 29453454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toward Developing Immunocompetent Diabetic Foot Ulcer-on-a-Chip Models for Drug Testing.
    Ejiugwo M; Rochev Y; Gethin G; O'Connor G
    Tissue Eng Part C Methods; 2021 Feb; 27(2):77-88. PubMed ID: 33406980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.